BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,424,720 | -14.9% | 142,400 | +12.9% | 0.00% | 0.0% |
| Q2 2023 | $4,026,373 | +8.0% | 126,100 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $3,726,454 | -29.9% | 121,700 | -10.4% | 0.00% | -25.0% |
| Q4 2022 | $5,315,049 | -16.3% | 135,900 | +2.0% | 0.00% | -20.0% |
| Q3 2022 | $6,350,000 | +27.7% | 133,300 | +3.7% | 0.01% | +66.7% |
| Q2 2022 | $4,974,000 | +7.7% | 128,500 | +59.4% | 0.00% | 0.0% |
| Q1 2022 | $4,618,000 | -20.7% | 80,600 | +10.3% | 0.00% | -25.0% |
| Q4 2021 | $5,825,000 | -3.3% | 73,100 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $6,021,000 | -30.7% | 69,200 | +2.5% | 0.00% | -20.0% |
| Q2 2021 | $8,688,000 | +173.4% | 67,500 | +70.0% | 0.01% | +150.0% |
| Q1 2021 | $3,178,000 | +1.6% | 39,700 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $3,127,000 | +344.2% | 38,300 | +33.9% | 0.00% | +100.0% |
| Q3 2020 | $704,000 | -12.1% | 28,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $801,000 | – | 28,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |